Platform trials streamline ALS therapy evaluation by rapidly ruling out ineffective drugs
Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...
manilatimes6d
Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)
PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...
Le Lézard7d
WhiteSwell Announces New Data Supporting Acute Decompensated Heart Failure Treatment with eLym System
WhiteSwell, a company pioneering a new paradigm in the treatment of acute decompensated heart failure (ADHF), announced today positive data from 21 patients treated in its DELTA-HF trial evaluating ...
Taiwan News8d
Europe Clinical Trials Market Participant-Centric Research Elevating Findings through Effective Focus Groups
Request To Download Free Sample of This Strategic Report @ Highlighted with 99 tables and 79 figures, this 186-page report ?Europe Clinical Trials Market 2022-2031 by Product Category (Drugs, Devices ...
Taiwan News8d
Global Clinical Trials Market Empathy in Action Enhancing Understanding through Focus Group Conversations
Request To Download Free Sample of This Strategic Report@ Highlighted with 148 tables and 111 figures, this 241-page report ?Global Clinical Trials Market 2022-2031 by Product Category (Drugs, ...
The Lancet9d
Drug development in psychiatry: 50 years of failure and how to resuscitate it
The past 50 years have seen remarkable advances in the science of medicine. The pharmacological treatments of disorders such as hypertension, immune disorders, and cancer are fundamentally different ...
PipelineReview.com10d
Boehringer’s nerandomilast meets primary endpoint in Phase III study FIBRONEER™-ILD, in progressive pulmonary fibrosis
INGELHEIM, Germany I 10, 2025 I Boehringer Ingelheim announced today that the FIBRONEERâ„¢-ILD trial met its primary endpoint, which was the ...
Le Lézard10d
Satellos Announces Completed Enrollment of all Four Multiple-Ascending Dose Cohorts for the Phase 1 Clinical Trial of SAT-3247 in Healthy Volunteers
Satellos Bioscience Inc. ("Satellos" or the "Company"), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, today ...
IEEE10d
Controlled Service Scheduling Scheme for User-Centric Software-Defined Network- Based Internet of Things
Abstract: Software Defined Networks (SDNs) support different applications’ data and control operations through operational plane differentiations. Such differentiations rely on the service providers’ ...
Health Affairs14d
Implications Of Public Policies For LGBTQI+ Population Health In The US
Anti-LGBTQI+ public policies overwhelmingly target youth and young adults, disrupting access to educational opportunities, ...
MedPage Today15d
Endovascular Therapy Hits a Wall for Stroke Clots Lodged in Mid-Size Vessels
In an editorial, J. Mocco, MD, of Mount Sinai Health System in New York City, characterized the DISTAL and ESCAPE-MeVO cohorts as being older and having higher baseline disability, which may have ...
PhaseV and Alimentiv Partner on Machine Learning-Based Solution to Tackle Challenges in GI Clinical Trials
PhaseV, a pioneer in software and machine learning (ML) for clinical trial optimization, announced today it has entered a strategic partnership with Alimentiv Inc., a global GI (gastrointestinal) ...